Lars Robbel
Articles
-
May 1, 2024 |
aiche.onlinelibrary.wiley.com | Paras Sharma |Lars Robbel |Michael Schmitt |Duygu Dikicioglu
1 INTRODUCTION The clinical and commercial success of mAbs has created a need to develop economic, efficient, and scalable production processes. MAb downstream unit operations require significant investment in development, scale-up and validation.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →